glipressin,
Gly Gly Gly 8 Lys vasopressin,
Gly-Gly-Gly-8-Lys-vasopressin,
glycylpressin,
glypressin,
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin,
Remestyp,
terlipressin,
terlypressin,
TGLVP,
tri-Gly-8-Lys- Vasopressin,
triglycyl lysine vasopressin,
triglycyl-(8-lysine)vasopressin,
triglycylvasopressin,
vasopressin, tri-Gly-8-Lys-,
Terlipressin,
14636-12-5,
Terlipressin acetate,
Terlipressina,
Terlipressine,
Terlipressinum,
Terlipressine [INN-French],
Terlipressinum [INN-Latin],
Terlipressina [INN-Spanish],
glypressin,
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin,
EINECS 238-680-8,
NCGC00185754-01,
Lucassin,
Terlipressin [BAN:INN],
Terlipressin [USAN:INN:BAN],
Lucassin (TN),
C52H74N16O15S2,
HS-2028,
AC1L2HDP,
Terlipressin (USAN/INN),
AC1Q5JB2,
DSSTox_CID_28878,
DSSTox_RID_83146,
DSSTox_GSID_48952,
SCHEMBL22699,
CHEMBL2135460,
DTXSID7048952,
CHEBI:135905,
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide,
Tox21_113374,
AKOS015994637,
CS-5769,
DB02638,
AN-11837,
HY-12554,
SC-47098,
CAS-14636-12-5,
LS-161411,
FT-0630417,
36T125,
D06672,
J-008213,
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbon,
(2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-5-amino-1-(carbamoylmethylcarbamoyl)pentyl]pyrrolidine-2-carboxamide,
(2S)-6-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{2-[2-(2-aminoacetamido)acetamido]acetamido}-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide,
(S)-N-((S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-19-(2-(2-(2-aminoacetamido)acetamido)a,
cetamido)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide,
glycylpressin,
Remestyp,
glipressin,
terlypressin,
Glypressin (TN),
triglycylvasopressin,
TGLVP,
Terlipressin [INN:BAN],
D0P4VX,
triglycyl lysine vasopressin,
UNII-7Z5X49W53P,
tri-Gly-8-Lys- Vasopressin,
vasopressin, tri-Gly-8-Lys-,
Triglycyl-8-lysine-vasopressin,
Gly Gly Gly 8 Lys vasopressin,
Gly-Gly-Gly-8-Lys-vasopressin,
triglycyl-(8-lysine)vasopressin,
7Z5X49W53P,
CID72081,
ACN-049452,
CS-O-02460,
C52-H74-N16-O15-S2,
N-(Glycylglycylglycyl)-8-L-lysinevasopressin,
Nalpha-glycylglycylglycyl-8-lysine-vasopressin,
C012078,
N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin,
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin,
N-(N- (N-glycylglycyl)glycyl)-8-L-lysinevasopressin,
D000077585,
Vasopressin, N-[N-(N-glycylglycyl)glycyl]-8-L-lysine-,
Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge: Cys4-Cys9),
(2s)-1-{[(4r,7s,10s,13s,16s,19r)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-n-{(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide(non-preferred name),